Itamar Stock Analysis

ITMR -  USA Stock  

USD 30.87  0.00  0.00%

The latest indifference towards the small price fluctuations of Itamar Medical may raise some interest from retail investors. The stock closed today at a share price of 30.87 on slow start in trading volume. The company directors and management did not add any value to Itamar Medical Ltd investors in December. However, most investors can still diversify their portfolios with Itamar Medical to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 0.21. The very small Stock volatility is a good signal to retail investors with longer-term investment horizons.
Please see Risk vs Return Analysis.

Itamar Stock Analysis 

 
Refresh
The Itamar Medical stock analysis report makes it easy to digest most publicly released information about Itamar Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Itamar Stock analysis module also helps to analyze the Itamar Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Itamar Stock Analysis Notes

About 58.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.11. Itamar Medical American had not issued any dividends in recent years. Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel. Itamar Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 257 people. To learn more about Itamar Medical Ltd call Gilad Glick at 972 4 617 7000 or check out http://www.itamar-medical.com.

Itamar Medical Quarterly Cost of Revenue

4.36 MillionShare

Itamar Medical American Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Itamar Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Itamar Medical Ltd or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Itamar Medical is not currently marked as verified by its exchange. Report It!

Itamar Medical American Upcoming and Recent Events

Earnings reports are used by Itamar Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Itamar Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report1st of March 2022
Next Earnings Report18th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End1st of March 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Itamar Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Itamar Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Itamar Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Itamar Medical American specific information freely available to individual and institutional investors to make a timely investment decision.

Itamar Medical Thematic Classifications

In addition to having Itamar Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

Itamar Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 505.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Itamar Medical's market, we take the total number of its shares issued and multiply it by Itamar Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Itamar Profitablity

Itamar Medical's profitability indicators refer to fundamental financial ratios that showcase Itamar Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Itamar Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Itamar Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Itamar Medical's profitability requires more research than a typical breakdown of Itamar Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (32.41) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (29.86) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.3.
Last ReportedProjected for 2022
Return on Average Assets(0.15) (0.16) 
Return on Average Equity(0.27) (0.29) 
Return on Invested Capital(0.33) (0.34) 
Return on Sales(0.21) (0.23) 

Management Efficiency

The entity has return on total asset (ROA) of (9.6) % which means that it has lost $9.6 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (21.04) %, meaning that it created substantial loss on money invested by shareholders. Itamar Medical management efficiency ratios could be used to measure how well itamar medical american manages its routine affairs as well as how well it operates its assets and liabilities. As of 01/19/2022, Return on Average Assets is likely to drop to -0.16. In addition to that, Return on Average Equity is likely to drop to -0.29. Itamar Medical Goodwill and Intangible Assets are relatively stable at the moment as compared to the past year. Itamar Medical reported last year Goodwill and Intangible Assets of 1.19 Million. As of 01/19/2022, Asset Turnover is likely to grow to 0.67, while Total Assets are likely to drop slightly above 58.8 M.
Last ReportedProjected for 2022
Book Value per Share 3.58  3.86 
Enterprise Value over EBIT(24.15) (26.06) 
Enterprise Value over EBITDA(30.51) (32.92) 
Price to Book Value 4.64  5.08 
Tangible Assets Book Value per Share 5.24  4.45 
Enterprise Value234.3 M217.7 M
Tangible Asset Value72.6 M57.9 M

Itamar Medical Technical and Predictive Indicators

About Itamar Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Itamar Medical stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Itamar shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Itamar Medical. By using and applying Itamar Stock analysis, traders can create a robust methodology for identifying Itamar entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(0.17) (0.17) 
Gross Margin 0.63  0.64 
Profit Margin(0.31) (0.33) 
Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel. Itamar Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 257 people.

Current Itamar Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Itamar analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Itamar analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
31.33Hold3Odds
Itamar Medical Ltd current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Itamar analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Itamar stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Itamar Medical American, talking to its executives and customers, or listening to Itamar conference calls.
Itamar Analyst Advice Details

Itamar Stock Analysis Indicators

Itamar Medical Ltd stock analysis indicators help investors evaluate how Itamar Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Itamar Medical shares will generate the highest return on investment. By understating and applying Itamar Medical stock analysis, traders can identify Itamar Medical position entry and exit signals to maximize returns.
Quick Ratio5.21
Fifty Two Week Low16.36
Revenue Growth43.00%
Shares Short Prior Month302.83k
Average Daily Volume Last 10 Day247.12k
Average Daily Volume In Three Month138.06k
Shares Percent Shares Out1.87%
Gross Margins68.94%
Forward Price Earnings-67.11
Float Shares10.06M
Fifty Two Week High30.91
Enterprise Value To Ebitda-22.62
Fifty Day Average30.57
Two Hundred Day Average24.64
Enterprise Value To Revenue6.24
Please see Risk vs Return Analysis. Note that the Itamar Medical American information on this page should be used as a complementary analysis to other Itamar Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for Itamar Stock

When running Itamar Medical American price analysis, check to measure Itamar Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Itamar Medical is operating at the current time. Most of Itamar Medical's value examination focuses on studying past and present price action to predict the probability of Itamar Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Itamar Medical's price. Additionally, you may evaluate how the addition of Itamar Medical to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go